[HTML] springer.comFull View

[HTML][HTML] Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing

J Hu, L Zhang, H Xia, Y Yan, X Zhu, F Sun, L Sun, S Li… - Genome medicine, 2023 - Springer
Background Immunotherapy has revolutionized cancer treatment, but most patients are
refractory to immunotherapy or acquire resistance, with the underlying mechanisms …
被引用次数：48 相关文章

Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing

J Hu, L Zhang, H Xia, Y Yan, X Zhu, F Sun… - Genome …, 2023 - search.proquest.com
Background Immunotherapy has revolutionized cancer treatment, but most patients are
refractory to immunotherapy or acquire resistance, with the underlying mechanisms …

Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing

J Hu, L Zhang, H Xia, Y Yan, X Zhu… - Genome …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Immunotherapy has revolutionized cancer treatment, but most patients are
refractory to immunotherapy or acquire resistance, with the underlying mechanisms …
[HTML] nih.gov

[HTML][HTML] Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing

J Hu, L Zhang, H Xia, Y Yan, X Zhu, F Sun… - Genome …, 2023 - ncbi.nlm.nih.gov
Background Immunotherapy has revolutionized cancer treatment, but most patients are
refractory to immunotherapy or acquire resistance, with the underlying mechanisms …

Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing.

J Hu, L Zhang, H Xia, Y Yan, X Zhu, F Sun, L Sun… - Genome …, 2023 - go.gale.com
Background Immunotherapy has revolutionized cancer treatment, but most patients are
refractory to immunotherapy or acquire resistance, with the underlying mechanisms …

Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing.

J Hu, L Zhang, H Xia, Y Yan, X Zhu, F Sun, L Sun… - Genome …, 2023 - europepmc.org
Background Immunotherapy has revolutionized cancer treatment, but most patients are
refractory to immunotherapy or acquire resistance, with the underlying mechanisms …
[HTML] biomedcentral.com

[HTML][HTML] Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing

J Hu, L Zhang, H Xia, Y Yan, X Zhu… - Genome …, 2023 - genomemedicine.biomedcentral …
Immunotherapy has revolutionized cancer treatment, but most patients are refractory to
immunotherapy or acquire resistance, with the underlying mechanisms remaining to be …

Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing.

J Hu, L Zhang, H Xia, Y Yan, X Zhu, F Sun… - Genome …, 2023 - search.ebscohost.com
Background: Immunotherapy has revolutionized cancer treatment, but most patients are
refractory to immunotherapy or acquire resistance, with the underlying mechanisms …
[PDF] biomedcentral.com

[PDF][PDF] Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing

J Hu, L Zhang, H Xia, Y Yan, X Zhu, F Sun… - 2023 - genomemedicine.biomedcentral …
Background Immunotherapy has revolutionized cancer treatment, but most patients are
refractory to immunotherapy or acquire resistance, with the underlying mechanisms …